Cargando…
Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12
BACKGROUND: Recent data indicate the Signal Transducer and Activator of Transcription 3 (STAT3) pathway is required for VEGF production and angiogenesis in various types of cancers. STAT3 inhibitors have been shown to reduce tumor microvessel density in tumors but a direct anti-angiogenic activity h...
Autores principales: | Bid, Hemant K., Oswald, Duane, Li, Chenglong, London, Cheryl A., Lin, Jiayuh, Houghton, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328460/ https://www.ncbi.nlm.nih.gov/pubmed/22530037 http://dx.doi.org/10.1371/journal.pone.0035513 |
Ejemplares similares
-
LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
por: Zuo, Mingxin, et al.
Publicado: (2015) -
The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
por: Ball, Sarah, et al.
Publicado: (2011) -
Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
por: Couto, Jason I, et al.
Publicado: (2012) -
A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin
por: Zhang, Ruijie, et al.
Publicado: (2021) -
LLL12B, a Novel Small-Molecule STAT3 Inhibitor, Induces Apoptosis and Suppresses Cell Migration and Tumor Growth in Triple-Negative Breast Cancer Cells
por: Pan, Li, et al.
Publicado: (2022)